Home > Healthcare > Medical Services > Lab Services > Egg Freezing and Embryo Banking Market

Egg Freezing and Embryo Banking Market Share

Report ID: GMI11172
Published Date: Sep 2024
Report Format: PDF

Download Free Sample

Egg Freezing and Embryo Banking Market Share

The market is highly fragmented, characterized by the presence of numerous players ranging from specialized fertility clinics to large hospitals and biotechnology companies. This fragmentation is driven by the diverse range of services offered, varying regulatory environments, and differing levels of technological adoption across regions.

Key players such as IVIRMA Global, CCRM Fertility, and Boston IVF dominate the landscape, leveraging technological advancements, superior success rates, and comprehensive service packages to maintain a competitive edge. These companies frequently engage in collaborations, partnerships, and mergers to bolster their market presence and expand their service portfolios.

The adoption of cutting-edge technologies like vitrification, artificial intelligence, and data analytics is a significant differentiator, enabling higher efficiency and better outcomes. Additionally, regional players adapt their services to align with local cultural and regulatory frameworks, further intensifying competition.

Egg Freezing and Embryo Banking Market Companies

Some of the eminent market participants operating in the egg freezing and embryo banking industry include:

Boston IVF
Carrot
CCRM Fertility
Cryos International
Extend Fertility LLC
Genea Pty Limited
IVIRMA Global
Monash IVF Group
New Hope IVF & Fertility Clinic
Ovation Fertility
Progyny, Inc.
ReproTech LLC
RMA Network
Shady Grove Fertility
Spring Fertility
WINFertilty

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The egg freezing and embryo banking industry was valued at approximately USD 4.2 billion in 2023 and is projected to grow at a CAGR of 16.7% from 2024 to 2032, driven by societal trends and advancements in reproductive technologies.

The embryo banking segment was worth USD 2.7 billion in 2023, as delayed parenthood due to career aspirations and lifestyle choices is leading individuals to preserve their reproductive potential for future use.

North America egg freezing and embryo banking industry is poised to reach USD 7.4 billion by 2032, propelled by a rapidly aging population, technological advancements, heightened public awareness, and the rising acceptance of assisted reproductive technologies.

CCRM Fertility, Cryos International, Extend Fertility LLC, Genea Pty Limited, IVIRMA Global, Monash IVF Group, and New Hope IVF & Fertility Clinic among others.